Acurx Pharmaceuticals, Inc.

ACXP ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
4 Jun 16, 2023 OWNERSHIP DOCUMENT
4 Jun 16, 2023 OWNERSHIP DOCUMENT
4 Jun 16, 2023 OWNERSHIP DOCUMENT
424B3 May 18, 2023 424B3
424B5 May 17, 2023 424B5
8-K May 17, 2023 FORM 8-K
10-Q May 12, 2023 10-Q
ARS Apr 27, 2023 ARS
DEFA14A Apr 27, 2023 DEFA14A
DEF 14A Apr 27, 2023 DEF 14A
PRE 14A Apr 17, 2023 PRE 14A
8-K Mar 16, 2023 8-K
S-8 Mar 15, 2023 FORM S-8
10-K Mar 15, 2023 10-K
4 Feb 24, 2023 OWNERSHIP DOCUMENT
4 Feb 24, 2023 OWNERSHIP DOCUMENT
4 Feb 24, 2023 OWNERSHIP DOCUMENT
SC 13G Feb 14, 2023
SC 13G Feb 14, 2023
8-K Nov 14, 2022 FORM 8-K
10-Q Nov 10, 2022 10-Q
424B3 Sep 23, 2022 424B3
EFFECT Sep 22, 2022
CORRESP Sep 20, 2022
UPLOAD Sep 19, 2022
← Newer Page 7 of 10 · 243 filings Older →